Harmony Biosciences Holdings (HRMY) Profit After Tax (2019 - 2026)

Harmony Biosciences Holdings has disclosed Profit After Tax across 8 years of filings, most recently posting $32.5 million for Q1 2026.

• Profit After Tax for Q1 2026 came in at $32.5 million, down 28.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $145.6 million (down 4.65% YoY), and the FY2025 annual result was $158.7 million, up 9.07% from the prior year.
• Profit After Tax came in at $32.5 million for Q1 2026 at Harmony Biosciences Holdings, up from $22.5 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $87.9 million in Q3 2022 to a low of $11.6 million in Q2 2024.
• The 5-year median for Profit After Tax is $38.3 million (2024), against an average of $38.1 million.
• Across the five-year window, Profit After Tax surged 1014.17% in 2022 and tumbled 66.21% in 2024, its largest moves.
• Harmony Biosciences Holdings' Profit After Tax stood at $48.5 million in 2022, then sank by 45.15% to $26.6 million in 2023, then soared by 85.95% to $49.5 million in 2024, then sank by 54.55% to $22.5 million in 2025, then soared by 44.48% to $32.5 million in 2026.
• The last three Profit After Tax figures came in at $32.5 million (Q1 2026), $22.5 million (Q4 2025), and $50.9 million (Q3 2025), per Business Quant data.